Navigation Links
Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis
Date:3/18/2013

MENLO PARK, California and BALLERUP, Denmark, March 18, 2013 /PRNewswire/ --

Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development of an oral treatment for psoriasis has reached an important milestone as Virobay has now initiated a Phase 1 clinical trial of VBY-891 - a selective cathepsin S inhibitor.

     (Logo: http://photos.prnewswire.com/prnh/20130221/595427)

The first Phase 1 trial of VBY-891 is a double-blind, randomized, placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of VBY-891 in healthy adults.

"The initiation of this Phase 1 trial represents a significant development objective for Virobay's collaboration with LEO Pharma," stated Robert Booth , Ph.D., Chief Executive Officer of Virobay. "Virobay has plans to initiate clinical studies with additional cathepsin inhibitors during 2013 as we seek to develop new therapies for underserved diseases. Published prelinical data suggest that cathepsin S inhibition may provide a therapeutic benefit in patients with dermatological disorders such as psoriasis. In addition, our own preclinical data with selective cathepsin S inhibitors has demonstrated efficacy in models of both psoriasis and atopic dermatitis," stated Robert Booth . "We look forward to assessing the data from these Phase 1 trials, which will incorporate the evaluation of several biomarkers, to guide our Phase 2 clinical development plans for VBY-891."

"Reaching this important milestone in our collaboration with Virobay brings us one step closer to provide an oral treatment for psoriasis patients. We believe that VBY-891 has the potential to provide an oral treatment that may alleviate symptoms of psoriasis. LEO Pharma strives to constantly ex
'/>"/>

SOURCE Virobay, Inc. and LEO Pharma A/S
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Educating, Informing, and Successfully Preparing the Marketplace for New Bio-Pharma Products
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
4. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
5. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
8. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
9. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
10. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
11. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... paid the September 12, 2014, regular quarterly dividend payment of ... PDL as of September 5, 2014, the record date. ... manages a portfolio of patents and royalty assets, consisting ... and license agreements with various biotechnology and pharmaceutical companies. ...
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... Drug Transfer Systems to 2020" report to their ... hazardous to humans has been receiving increasing amounts of ... substances become more clearly understood. For caregivers and their ... of attempts to mitigate exposure to cytotoxic drugs is ...
(Date:9/15/2014)... -- Research and Markets has announced the addition ... Tests, 9th Edition" report to their offering. ... testing market and all of its segments, providing customers with ... For Business Planning. This is the ninth edition ... 2013 and early 2014. New entrants, new technologies have entered ...
Breaking Medicine Technology:PDL BioPharma Completes Regular Quarterly Dividend Payment 2Closed Drug Transfer Systems to 2020 2Closed Drug Transfer Systems to 2020 3The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... 17, 2011 Attorneys representing a group of U.S. citizens ... the drug thalidomide have filed a lawsuit in federal court ... show the drug was widely distributed in the United States. ... to respond to a number of Freedom of Information Act ...
... WASHINGTON, Nov. 17, 2011 The proliferation of brand ... generics to more expensive brands, will increase costs by ... employers, unions, and state employee plans, according to new ... Care Management Association (PCMA).   The use of these ...
Cached Medicine Technology:Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 2Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 3Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $617 Million in Wisconsin 2
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... Bard, Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. According ... a Final Order on September 10th that provides for ... Order notes that none of the affected plaintiffs has ...
(Date:9/15/2014)... large cohort analysis from the prospective Prostate, Lung, Colorectal ... who had moderate baldness affecting both the front and ... at a 40% increased risk of developing aggressive prostate ... poorer prognosis relative to non-aggressive prostate cancer) later in ... no significant link between other patterns of baldness and ...
(Date:9/15/2014)... The White House has recently begun shifting ... jail and prison and toward helping them access addiction ... positive change. , The nation is currently grappling with ... to an article from The Washington Post , ... away from using the criminal justice system to address ...
(Date:9/15/2014)... By Maureen Salamon ... (HealthDay News) -- Pediatricians prescribe antibiotics about twice as ... and throat infections, a new study indicates. More ... children and teens may be unnecessary, according to researchers ... excess antibiotic use not only fails to eradicate children,s ...
(Date:9/15/2014)... shown that certain brain regions are associated with ... decision-making. , How and where these specific abilities ... cognition is still under investigation. However, researchers at ... St. Louis, Missouri, believe that several hub regions ... function as an integrated network. , In research ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2Health News:White House Shifts Policy on Drugs 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Network measures predict neuropsychological outcome after brain injury 2
... its new patient-education website, www.CLIclinicalstudy.com , is now “live”. ... enrolling in the Company’s clinical trial and their referring physicians ... underlies it, and the location of the study’s sites. ... ...
... help consumers get,accurate, dependable information about healthcare ... support consumer,engagement and improved quality in healthcare, ... consumer-focused, internet-based public,reporting. These guidelines will assist ... in an evidence-based and,consumer-friendly format that can ...
... (October 26, 2008) A single administration of a novel, ... that were more than 20 times higher than those ... according to a study by NanoBio Corporation. The new ... produce this effect. , Results of the study are ...
... blood that was 29 days or older faced twice the ... who receive a transfusion of stored blood that is 29 ... or more serious infections compared to those who get "fresher" ... that current U.S. regulations set the upper limit for blood ...
... of candy, ST. LOUIS, Oct. 28 The ... year, and a sizeable portion of that indulgence,is eaten ... will,simply create an expanded beltline. However, for the more ... can pose more,tricky consequences., To help ease candy ...
... Resources to Prevent Millions in Lost Wages, SAN ... of the flu are reported annually, financially challenging working,families ... days. QuickHealth meets,the challenge by providing updated information and ... to clarify treatment options and to help,them make better ...
Cached Medicine News:Health News: Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 3Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 4Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 5Health News:New intranasal influenza vaccine triggers robust immunity with significantly less antigen 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 3Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 2Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 3Health News:75 Million Missed Work Days Expected This Flu Season 2Health News:75 Million Missed Work Days Expected This Flu Season 3
... an ultra-capacity bacterial growth system, combines ... a high-capacity format for bacterial growth. ... with Bioneer's HT-Prep™ Automatic DNA Extractor. ... advantages over traditional floor shakers. Plate-holding ...
Inquire...
... Refrigerated incubators,Two refrigerated incubators ... life and life cycle,testing. Microprocessor ... digital temperature display. High/low audible ... contacts. Additional internal chamber safety ...
Inquire...
Medicine Products: